206 related articles for article (PubMed ID: 4040658)
1. Characterization of two monoclonal antibodies against human tissue-type plasminogen activator.
Schleef RR; Sinha M; Loskutoff DJ
Thromb Haemost; 1985 Apr; 53(2):170-5. PubMed ID: 4040658
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of epitopes on human tissue plasminogen activator recognised by a group of monoclonal antibodies.
MacGregor IR; Micklem LR; James K; Pepper DS
Thromb Haemost; 1985 Feb; 53(1):45-50. PubMed ID: 2581330
[TBL] [Abstract][Full Text] [Related]
3. Production and characterization of monoclonal antibodies against tissue-type plasminogen activator.
Ding H; Wang JY; Song HY
Chin J Biotechnol; 1990; 6(3):223-7. PubMed ID: 2129498
[TBL] [Abstract][Full Text] [Related]
4. [Use of monoclonal antibodies in the diagnosis of fibrinolysis].
Wojta J; Korninger C; Kirchheimer J; Hattey E; Turcu L; Binder BR
Wien Klin Wochenschr; 1985 Mar; 97(5):244-8. PubMed ID: 4039506
[TBL] [Abstract][Full Text] [Related]
5. Characterization of monoclonal antibodies to human tissue-type plasminogen activator: catalytic inhibition and one-two chain discriminatory reactivities.
Stigbrand T; Frängsmyr L; Bergsdorf N; Wallen P
Thromb Haemost; 1989 Sep; 62(2):742-7. PubMed ID: 2479112
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies detecting plasminogen activators on the membrane of leukemic lymphoid cells of T-cell origin.
Stünkel KG; Thiel E; Opitz HG; Schlumberger HD; Opitz U; Catovsky D; Klimetzek V
Cancer Detect Prev Suppl; 1987; 1():269-77. PubMed ID: 3500778
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies towards the fast inhibitor of tissue plasminogen activator from human plasma and serum.
Urdén G; Johansson U; Chmielewska J; Brandt J; Wiman B
Thromb Haemost; 1986 Jun; 55(3):383-7. PubMed ID: 3092395
[TBL] [Abstract][Full Text] [Related]
9. A fibrin specific monoclonal antibody which interferes with the fibrinolytic effect of tissue plasminogen activator.
Gargan PE; Ploplis VA; Scheu JD
Thromb Haemost; 1988 Jun; 59(3):426-31. PubMed ID: 3142080
[TBL] [Abstract][Full Text] [Related]
10. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody to human tissue plasminogen activator.
Matsuo O; Tanbara Y; Okada K; Bando H; Nagoya T
Thromb Res; 1984 Dec; 36(6):517-26. PubMed ID: 6442014
[TBL] [Abstract][Full Text] [Related]
12. [Functional characterization of a monoclonal antibody which interferes with the binding of t-PA to fibrin].
Orbe J; Montes R; Chordá C; Páramo JA; Rocha E
Sangre (Barc); 1994 Aug; 39(4):261-6. PubMed ID: 7985055
[TBL] [Abstract][Full Text] [Related]
13. Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein.
Cugno M; Cicardi M; Colucci M; Bisiani G; Merlini PA; Spinola A; Paonessa R; Agostoni A
Thromb Haemost; 1996 Aug; 76(2):234-8. PubMed ID: 8865537
[TBL] [Abstract][Full Text] [Related]
14. Characterization of plasminogen activator produced by an established cell line from human ovary.
Matsuo C; Fukao H; Matsuo O
J Cell Physiol; 1988 Feb; 134(2):253-60. PubMed ID: 3126195
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
Kuroki M; Kuroki M; Koga Y; Matsuoka Y
J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and application of monoclonal antibodies against PAI-1.
Ding H; Wu X; Zhou X; Zhu Y; Song H
Chin J Biotechnol; 1994; 10(2):121-8. PubMed ID: 7803688
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activators in nude mice xenotransplanted with human tumorigenic cells.
Colombi M; Bellotti D; De Petro G; Barlati S
Invasion Metastasis; 1995; 15(1-2):22-33. PubMed ID: 7672929
[TBL] [Abstract][Full Text] [Related]
19. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice.
Declerck PJ; Verstreken M; Collen D
Thromb Haemost; 1995 Nov; 74(5):1305-9. PubMed ID: 8607114
[TBL] [Abstract][Full Text] [Related]
20. Hapten-specific B cell repertoire probed by hybridoma technology: selection and characterization of representative clonotypes from the antibody-forming cell pool.
Bloor AG; Jou Y; Hoeplinger C; Gartner JE; Mayers GL; Bankert RB
J Immunol; 1982 Mar; 128(3):1443-9. PubMed ID: 6173438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]